Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists trace spread of contagious canine cancer
Brown dog
The process of swapping mitochondrial DNA has occurred at least five times since the original cancer arose.
Evolutionary family tree shows how tumours are related to each other

A transmissible form of cancer that spreads between dogs during mating has been traced for the first time.

‘Canine transmissible venerial tumour’ (CTVT) is a cancer that spreads between dogs through the transfer of living cancer cells.  

The disease is the oldest and most prolific lineage known in nature - dating back approximately 11,000 years - and usually manifests as genital tumours.

Previous research into the disease found that, at occasional points in history, mitochondrial DNA has transferred from infected dogs to their tumours - and then to tumour cells in subsequently infected dogs.

Now, in a new study, researchers show that this process of swapping mitochondrial DNA has occurred at least five times since the original cancer arose. The discovery has enabled them to create an evolutionary ’family tree’ showing how the tumours are related to each other.

Furthermore, the unusual juxtaposition of different types of mitochondrial DNA within the same cell unexpectedly revealed that cancer cells can shuffle or ‘recombine’ DNA from different mitochondria.

Lead author Andrea Strakova, from the Department of Veterinary Medicine at the University of Cambridge, explains: “At five distant time-points in its history, the cancer has ‘stole’ mitcochondrial DNA formats host, perhaps to help the tumours survive. This provides is with a set of unique genetic takes to trace how dogs have travelled over the globe over the last few hundred years.”

One of the most surprising findings from the study related to how mitochondrial DNA transfers and mixes between the tumour and the host.

The researchers found that mitochondrial DNA molecules from host cells that have migrated into tumour cells occasionally fuse with the tumour’s own mitochondrial DNA, sharing host and tumour DNA in a process known as ‘recombination’. This is the first time this process has been observed in cancers.

Scientists are now looking to explore how this process may help cancer cells to survive and if blocking it may stop cancer cells from growing.

The study, Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer, is published in the journal eLife

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.